Eugenol β-amino/β-alkoxy alcohols with selective anticancer activity

• Autor(a) principal: Teixeira, Cláudia
• Data de Publicação: 2022
• Outros Autores: Pereira, Renato B., Pinto, Nuno F. S., Coelho, Catarina M. M., Fernandes, Maria José G., Fortes, A. Gil, Gonçalves, M. Sameiro T., Pereira, David M.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: https://hdl.handle.net/1822/79798
• topic: Eugenol; β-amino alcohols; β-alkoxy alcohols; Cytotoxicity; Apoptosis; Anticancer; beta-amino alcohols; beta-alkoxy alcohols; Science & Technology

Eugenol, 4-allyl-2-methoxyphenol, is the main constituent of clove essential oil and has demonstrated relevant biological activity, namely anticancer activity. Aiming to increase this activity, we synthesized a series of eugenol β-amino alcohol and β-alkoxy alcohol derivatives, which were then tested against two human cancer cell lines, namely gastric adenocarcinoma cells (AGS) and lung adenocarcinoma cells (A549). An initial screening was performed to identify the most cytotoxic compounds. The results demonstrated that three β-amino alcohol derivatives had anticancer activity that justified subsequent studies, having been shown to trigger apoptosis. Importantly, the most potent molecules displayed no appreciable toxicity towards human noncancer cells. Structure-activity relationships show that changes in eugenol structure led to enhanced cytotoxic activity and can contribute to the future design of more potent and selective drugs.